Julien Rongère
Consejero General en AC IMMUNE SA .
Cargos activos de Julien Rongère
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AC IMMUNE SA | Consejero General | 01/07/2017 | - |
Historial de carrera de Julien Rongère
Antiguos cargos conocidos de Julien Rongère.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Apoxis SA
 Apoxis SA Pharmaceuticals: MajorHealth Technology Apoxis SA develops therapeutics for the treatment of cancer and immunological diseases based on the mechanisms underlying apoptosis or cell death. The company particularly focuses on diseases with unmet medical needs and high commercial potential. It's lead product, APO866, is a novel small molecule therapeutic for the treatment of a range of cancers. The product is also being evaluated in a range of cancers in combination with commonly used chemo and radiotherapies in preclinical studies. It's oncology portfolio also includes APO010, a protein therapeutic that was developed using the company’s proprietary multimerization technology. The company is headquartered in Lausanne, Switzerland. | Corporate Officer/Principal | - | - |
Celgene Switzerland SARL
 Celgene Switzerland SARL Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Switzerland SARL is a Swiss biopharmaceutical company. The company is based in Boudry, Switzerland. | Consejero General | - | - |
Formación de Julien Rongère.
| University of Aberdeen | Graduate Degree |
| University of Lausanne | Doctorate Degree |
Estadísticas
Internacional
| Suiza | 5 |
| Reino Unido | 2 |
Operativa
| General Counsel | 2 |
| Graduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Empresas privadas | 2 |
|---|---|
Celgene Switzerland SARL
Celgene Switzerland SARL Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Switzerland SARL is a Swiss biopharmaceutical company. The company is based in Boudry, Switzerland. | Health Technology |
Apoxis SA
Apoxis SA Pharmaceuticals: MajorHealth Technology Apoxis SA develops therapeutics for the treatment of cancer and immunological diseases based on the mechanisms underlying apoptosis or cell death. The company particularly focuses on diseases with unmet medical needs and high commercial potential. It's lead product, APO866, is a novel small molecule therapeutic for the treatment of a range of cancers. The product is also being evaluated in a range of cancers in combination with commonly used chemo and radiotherapies in preclinical studies. It's oncology portfolio also includes APO010, a protein therapeutic that was developed using the company’s proprietary multimerization technology. The company is headquartered in Lausanne, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Julien Rongère
- Experiencia